SAROGLITAZAR

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C25H29NO4S
Molecular Weight	439.567
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of SAROGLITAZAR

Structure Search

SMILES

CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C3=CC=C(SC)C=C3)C=C1)C(O)=O

InChI

InChIKey=MRWFZSLZNUJVQW-DEOSSOPVSA-N

InChI=1S/C25H29NO4S/c1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20/h5-14,24H,4,15-17H2,1-3H3,(H,27,28)/t24-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C25H29NO4S
Molecular Weight	439.567
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 05:33:49 UTC 2023` Edited by `admin` on `Sat Dec 16 05:33:49 UTC 2023`
Record UNII	E0YMX3S4JD
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SAROGLITAZAR

Official Name

English

saroglitazar [INN]

Common Name

English

BENZENEPROPANOIC ACID, .ALPHA.-ETHOXY-4-(2-(2-METHYL-5-(4-(METHYLTHIO)PHENYL)-1H-PYRROL-1-YL)ETHOXY)-, (.ALPHA.S)-

Common Name

English

(2S)-2-ETHOXY-3-(4-(2-(2-METHYL-5-(4-(METHYLSULFANYL)PHENYL)-1H-PYRROL-1-YL(ETHOXY)PHENYL)PROPANOIC ACID

Common Name

English

Saroglitazar [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C98233

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

Code System Code Type Description

SMS_ID

100000174930

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

EPA CompTox

DTXSID10197819

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

CAS

495399-09-2

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

INN

9677

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

WIKIPEDIA

SAROGLITAZAR

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

CHEBI

134708

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

DRUG CENTRAL

5047

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

NCI_THESAURUS

C152303

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

PUBCHEM

60151560

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

FDA UNII

E0YMX3S4JD

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

DRUG BANK

DB13115

Created by admin on Sat Dec 16 05:33:49 UTC 2023 , Edited by admin on Sat Dec 16 05:33:49 UTC 2023

PRIMARY

Related Record Type Details


					AL17N8ZSWL

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA

TARGET -> AGONIST

Comments:

sarogli tazar has a predominant affinity for the PPAR-α isoform, and an intermediate affinity for PPAR-γ


					2PDN1S3FVX

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA

TARGET -> AGONIST

Comments:

sarogli tazar has a predominant affinity for the PPAR-.ALPHA. isoform, and an intermediate affinity for PPAR-.GAMMA.


					K8V5DLS63R

SAROGLITAZAR MAGNESIUM

SALT/SOLVATE -> PARENT

Related Record Type Details


					E0YMX3S4JD

ACTIVE MOIETY